ABSTRACT. To investigate mechanisms of ATP depletion in human umbilical vein endothelial cells after oxidant injury, we studied the relationship between DNA damage, activation of the DNA-repairing enzyme poly ADP-ribose polymerase, NAD depletion, and ATP depletion. We found that oxidant stress generated with hypoxanthine-xanthine oxidase and glucose-glucose oxidase resulted in profound DNA damage. When endothelial cells were exposed to 25 and 50 mU/ml xanthine oxidase for 60 min, the percentage of double-stranded DNA was significantly reduced (p < 0.05) to 15.2 f 1.2 and 4.6 f 0.5%, respectively, compared to 75.7 f 3.9% for control cells. When endothelial cells were exposed to 25 and 50 mU/ml glucose oxidase for 60 min, the percentage of double-stranded DNA was significantly (p < 0.05) reduced to 35.0 f 1.5% and 9.9 f 7.7%, respectively, compared to 73.2 f 2.4% for control cells.
ATP and NAD levels declined simultaneously with DNA damage. Because activation of the DNA-repairing enzyme poly ADP-ribose polymerase can consume NAD sufficient to interfere with ATP synthesis, we studied NAD and ATP levels after oxidant injury when ADP-ribose polymerase was inhibited with 3-aminobenzamide and nicotinamide. When poly ADP-ribose polymerase was inhibited, NAD levels remained normal, but ATP depletion was not prevented. We conclude that oxidant injury to human umbilical vein endothelial cells results in profound DNA damage and NAD and ATP depletion. NAD depletion results from activation of poly ADP-ribose polymerase, but this phenomenon is not the mechanism of ATP depletion in human umbilical vein endothelial cells. (Pediatr Res 25:97-101, 1988) Abbreviations FCS, fetal calf serum HBSS + A, Hank's balanced salt solution with 0.5% albumin NAD, nicotinamide adenine dinucleotide SBTI, soybean trypsin inhibitor PES, phenazine ethosulfate During the past several years, research has focused on the role of oxidant injury in the pathophysiology of several human diseases. Tissue injury as a result of oxygen radical generation may be involved in the pathogenesis of inflammatory diseases, aging, carcinogenesis, and ischemia-reperfusion injury ( 1-3). The adult respiratory distress syndrome, emphysema, atherosclerosis, mycocardial infarction, glomerulonephritis, and rheumatoid arthritis are a few specific diseases in which oxidant stress is thought to play a role (1) (2) (3) . That oxidant stress has been implicated in the pathophysiology of several diseases suggests that reactive oxygen molecules may be the final common mediator of tissue injury after a number of diverse insults including metabolic, toxic, immunologic, and hypoxic.
The precise pathophysiologic mechanisms by which reactive oxygen molecules induce cellular injury are unknown. Oxygen radicals are capable of inducing damage to proteins through sulkydryl oxidation, membranes via lipid peroxidation and nucleic acids by induction of DNA strand breaks (3, 4) . After oxidant injury, several metabolic alterations occur, including activation of the glutathione-redox cycle, elevation of intracellular calcium, and depletion of cellular ATP stores (5-9). ATP levels decline as an early response to oxidant injury, whereas cell lysis indicated by "Cr release occurs considerably later (8) . In lymphocytes and the P388Dl cell line, ATP depletion results from NAD depletion sufficient to interfere with ATP synthesis; NAD depletion is a result of activation of the DNA-repairing enzyme poly ADP-ribose polymerase, which consumes NAD (10) (11) (12) .
Because the endothelial cell is in close contact with polymorphonuclear leukocytes, monocytes, and mesangial cells that may each produce oxygen radicals when activated, the endothelial cell is at high risk for oxidant injury. In addition, because xanthine oxidase is primarily localized to capillary endothelial cells (1 3), the endothelium is at high risk for oxidant injury during reperfusion after ischemia. To investigate the mechanism responsible for the decline in endothelial cell ATP levels after oxidant injury, we measured NAD levels and DNA damage after oxidant injury with hypoxanthine-xanthine oxidase and glucose-glucose oxidase. In addition, we determined protection provided by 3-aminobenzamide and nicotinamide, each inhibitors of poly ADP-ribose polymerase.
METHODS

Materials.
The following materials were used in these studies: hypoxanthine, xanthine oxidase (grade I), glucose oxidase (type V), SBTI, Triton X-100, alcohol dehydrogenase, luciferin-luciferase, ATP, NAD, ethanol, catalase, perchloric acid, mesoinositol, urea, sodium dodecylsulfate, mercaptoethanol, ethidium bromide (Sigma Chemical Co., St. Louis, MO); N-bis-2-hydroxyethyl-glycine sodium bicine, sodium iodoacetate, and thiazolyl blue (Calbiochem, San Diego, CA); normal human albumin (Armour Pharmaceutical Co., Kankakee, IL), M 199, FCS, penicillin-streptomycin, HEPES buffer, HBSS, trypsin EDTA, (GIBCO, Grand Island, NY); collagenase (type 11) (Worthington Diagnostic Systems, Inc., Freehold, NJ); PES (ICN Biochemicals, Cleveland, OH); diaminocyclohexanetetraacetic acid (Aldrich Chemical Co., Milwaukee, WI).
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Endothelial cell cultures. Human endothelial cells were obtained from umbilical veins by collagenase digestion (6) . The endothelial cells were incubated in MI99 with 20% pooled normal human serum, penicillin (100 U/ml), streptomycin (100 pg/ml) and 20 mM HEPES buffer at 37°C in a humidified environment containing 5% COz for 4-7 days until the cells were a confluent monolayer. Cells from at least 3 cords were then passed and plated onto 24-well Costar plates (Costar Data Packaging Corp., Cambridge, MA) at a density of approximately 50,000 cells/cm2 in MI99 containing 20% FCS, penicillin (100 U/ml), streptomycin (100 pg/ml), and 20 mM HEPES buffer. After approximately 3 days, the cells were a confluent monolayer; at confluency, one well of a 24-well Costar plate contains approximately 200,000 cells. All experiments were performed with cells from the first or second passage. Cells were identified as endothelial by a cobblestone appearance with phase contrast microscopy and positive direct immunofluorescence for factor VIII-related antigen in more than 98% of the cells.
DNA damage. We determined DNA damage with the fluorometric technique used by Birnboim et al. (14) as adapted to endothelial cells by other investigators (1 5) . This assay monitors the unwinding of DNA in alkaline solutions by measuring the fluorescence of ethidium bromide binding to residual doublestranded DNA. Endothelial cells in 24-well Costar plates were incubated with 0, 25, and 50 mU/ml glucose oxidase with 5.5 mM glucose and 0, 25, and 50 mU/ml xanthine oxidase with 5.0 mM hypoxanthine and 5 mg/ml SBTI for 15,30,45, and 60 min. The supernatant was aspirated, endothelial cells were removed with trypsin EDTA, cells from four replicate wells were pooled and were resuspended in 1 ml of 0.25 M meso-inositol, 10 mM sodium phosphate, 1 mM MgCl2, pH 7.2. Samples consisting of 200 pl were dispensed to four sets of test tubes. In one, alkaline unwinding was prevented (representing total double-stranded DNA); in another tube, the cells were sonicated to allow maximum unwinding to determine background fluorescence; in the two remaining tubes, unwinding was not altered. At the end of the alkaline incubation, 1.5 ml of 6.7 pglml ethidium bromide in 13.3 mM NaOH was added and fluorescence was read in a Perkin-Elmer MPF 44B fluorescent spectrophotometer (Perkin-Elmer Corp. Instrument Div., Nonvalk, CT)
at an excitation wavelength of 520 nm and an emission wavelength of 590 nm. The percentage of double-stranded DNA was calculated by (sample fluorescence -background fluorescence)/ (total fluorescence -background fluorescence) x 100.
ATP levels. Endothelial cells in 24-well Costar plates were incubated with 10, 25, and 50 mU/ml glucose oxidase with 5.5 mM glucose or 10,25, and 50 mU/ml xanthine oxidase with 5.0 mM hypoxanthine with 5 mg/ml SBTI in a final volume of 400 p1 HBSS + A for 30, 60, and 90 min. At the completion of experiments, endothelial cells were solubilized with 500 p1 of 0.5% Triton and acidified with 100 pl 0.6M perchloric acid and placed on ice until assayed. At the time of assay, the endothelial cell suspension was diluted 1:800 with 10 mM potassium phosphate buffer containing 4 mM MgS04 (pH 7.4); 500 p1 of this mixture was added to 1 ml of 50 mM sodium arsenate buffer containing 20 mM MgS04 (pH 7.4) to which 25 p1 of 40 mg/ml luciferin-luciferase was added. Light emission was recorded precisely at 20 s with a Packard p counter (Hewlett-Packard Co., Palo Alto, CA) accepting signals out of coincidence (16) . ATP levels were expressed as pmol/pg of protein. Protein content was determined on a portion of the cell sample by the method of Lowry with bovine serum albumin as the standard (17) . To determine if reactive oxygen molecules caused direct degradation of ATP, glucose-glucose oxidase (10, 25, and 50 mU/ml) and hypoxanthine-xanthine oxidase (10, 25, and 50 mU/ml) were each incubated with ATP standard for 1 h. To determine if ATP was in the extracellular fluid after oxidant injury, ATP levels were determined on supernants of cells exposed to 10, 25, and 50 mU/ml glucose oxidase and 10, 25, and 50 mU/ml xanthine oxidase for 60 min.
NAD levels. NAD levels were determined by an enzymatic cycling assay (18) . Endothelial cells in 24-well Costar plates were incubated with 10, 25, and 50 mU/ml glucose oxidase with 5.5 mM glucose or 10, 25, and 50 mU/ml xanthine oxidase with 5.0 mM hypoxanthine with 5 mg/ml SBTI for 30,60, and 90 min. At the completion of experiments, endothelial cells were solubilized with 500 p1 of 0.5% Triton, acidified with 100 pl of 0.6 M perchloric acid, neutralized with KOH; 50 p1 of the sample were then added to 1.15 ml of reaction mixture containing 120 pm sodium bicine, 600 pm ethanol, 2 pm PES, and 0.5 pm thiazolyl blue. The samples were incubated at 37" C for 60 min after the addition of 0.2 mg alcohol dehydrogenase. The absorbance was measured at 570 nm, the amount of NAD present was determined with a standard curve, and NAD levels were normalized to cell protein levels as for ATP.
Inhibition studies. To determine if NAD and ATP depletion is a result of activation of the enzyme poly ADP-ribose polymerase, ATP and NAD levels were determined after oxidant injury with and without two inhibitors of poly ADP-ribose polymerase, nicotinamide and 3-aminobenzamide. NAD and ATP levels were determined in endothelial cells exposed to 10, 20, 30, 40, and 50 mU/ml glucose oxidase with 5.5 mM glucose for 60 min and 10, 20, 30, 40, and 50 mU/ml xanthine oxidase with 5.0 mM hypoxanthine for 60 min with no inhibitor, with 5.0 mM or 10.0 mM nicotinamide, and with 5.0 mM 3-aminobenzamide. Scavenger experiments. To determine which oxygen radical(s)
mediates DNA damage, endothelial cell monolayers in 24-well plates were incubated for 60 min with 25 mU/ml xanthine oxidase and 5.0 mM hypoxanthine with 5 mg/ml SBTI or 25 mU/ml glucose oxidase with 5.5 mM glucose and either no scavenger or 100 pg/ml superoxide dismutase, 100 pglml catalase, 0. (Fig. 1A) . When endothelial cells were exposed to 25 and 50 mU/ml xanthine oxidase for 60 min, the percentage of double-stranded DNA was significantly ( p < 0.05) reduced to 15.2 + 1.2 and 4.6 +. 0.5, respectively, compared to 75.7 f 3.9% for control cells (Fig. 1B) . Endothelial cells exposed to 25 and 50 mU/ml glucose oxidase with 5.5 mM glucose or 25 and 50 mU/ml xanthine oxidase with 5.0 mM hypoxanthine for shorter periods of time also demonstrated DNA damage. When endothelial cells were incubated with 25 and 50 mU/ml glucose oxidase for 60 min in the presence of 100 pg/ml catalase, the percentage of double-stranded DNA (70.0 + 2.0 and 71. percentage of residual double-stranded was 6.9 k 1.0% (compared to 74.0 + 3.7% for control cells) for one cohort and 12.2 + 3.6% (compared to 79.1 + 6.3% for control cells) for another cohort.
ATP and NAD levels. When endothelial cells were exposed to oxygen radicals generated by 10, 25, and 50 mU/ml glucose oxidase or 10, 25, and 50 mU/ml xanthine oxidase for 30, 60, and 90 min, ATP levels declined (Fig. 2) . The decrease in endothelial cell ATP levels was not the' result of a direct effect of glucose oxidase, xanthine oxidase, or the oxygen products generated because there was more than 95% recovery of ATP standard incubated with 10, 25, and 50 mU/ml glucose oxidase with 5.5 mM glucose and xanthine oxidase with 5.0 mM hypoxanthine for 1 h (data not shown). The decline in ATP levels was not the result of direct release of ATP from the cell as ATP was not detected in supernatants when endothelial cells were exposed to 10, 25, and 50 mU/ml glucose oxidase or 10,25, and 50 mU/ml xanthine oxidase for 60 min with or without inhibitors of poly ADP-ribose polymerase. When endothelial cells were exposed to 10, 25, and 50 mU/ml glucose oxidase for 60 min, NAD levels fell to 1 .OO + 0.13, 0.25 k 0.08, and 0.105 + 0.085 pm01/~g protein, respectively, compared to 1.24 k 0.16 pmol/ pg protein for control cells (Fig. 2) . When endothelial cells were exposed to 10, 25, and 50 mU/ml xanthine oxidase for 60 min, NAD levels fell to 1.06 + 0.06, 0.50 + 0.02, and 0.3 1 k 0.06 pmol/pg protein, respectively, compared to 1.30 f 0.24 pmol/ pg protein for control cells (Fig. 2) . Thus, in each oxygen radical generating system, the NAD levels fell simultaneously with the decline in ATP levels (Fig. 2) .
Inhibition studies. As shown in Table 1 , ATP and NAD levels declined when endothelial cells were exposed to glucose-glucose oxidase and hypoxanthine-xanthine oxidase. When poly ADPribose polymerase was inhibited with 5.0 mM 3-aminobenzamide, NAD levels remained normal at each dose of glucose oxidase and xanthine oxidase. When poly ADP-ribose polymerase was inhibited with 5.0 mM nicotinamide, NAD depletion was prevented. NAD levels remained normal at lower doses of glucose oxidase and xanthine oxidase and at higher doses, substantial protection of NAD levels was observed. When poly ADP-ribose polymerase was inhibited with 5.0 and 10.0 mM nicotinamide in another endothelial cell cohort, 5.0 mM nicotinamide again resulted in substantial protection from NAD depletion, whereas 10.0 mM nicotinomide resulted in complete protection from NAD depletion. In contrast, ATP depletion was not prevented by inhibition of poly ADP-ribose polymerase in either oxygen radical-generating system. ATP was not detected in the endothelial cell supernatants in the presence or absence of 5.0 mM aminobenzamide or 5.0 mM nicotinamide. These results suggest that NAD depletion results from activation of the enzyme poly ADP-ribose polymerase but that NAD depletion does not account for the alterations in ATP metabolism.
Scavenger experiments. When endothelial cells were incubated with 25 mU/ml glucose oxidase and various oxygen radical scavengers, only catalase (scavenger of hydrogen peroxide) prevented DNA damage, whereas superoxide dismutase (scavenger of superoxide anion), dimethylsulfoxide (scavenger of hydroxyl radical), and deferoxamine (chelator of iron to prevent ironcatalyzed hydroxyl radical formation) did not prevent DNA damage (Fig. 3A) . Similar results were obtained with endothelial cells exposed to 25 mU/ml xanthine oxidase and 5.0 mM hypoxanthine for 60 min (Fig. 3B) . DISCUSSION Recently, oxidant injury has been recognized to play a role in the pathophysiology of several diseases, including aging, carcinogenesis, oxygen toxicity, adult respiratory distress syndrome, reperfusion after ischemia, and immune-mediated diseases such as glomerulonephritis, rheumatoid arthritis, and vasculitis (1-3). In addition, several diseases of the premature newborn, including bronchopulmonary dysplasia, retinopathy of prematurity, necrotizing enterocolitis, and possibly intraventricular hemorrhage may be a result of oxidant injury (19) . Successful antioxidant therapy in these diseases will depend upon a better understanding of the mechanisms of cellular injury after oxidant stress. The precise mechanism(s) of cellular injury and metabolic alterations after oxidant injury are not well defined. In bovine endothelial cells, in the P388D1 cell line, and in lymphocytes, oxidant stress has been found to result in depletion of ATP (8) (9) (10) . In the P3888D1 cell line and in lymphocytes, the mechanism of ATP depletion appears to result from activation of the enzyme poly ADP-ribose polymerase (1 1-13 ). Oxidant injury results in DNA damage (20, 21) , which stimulates the DNA-repairing enzyme poly ADP-ribose polymerase to repair oxidant-induced DNA damage (22, 23) . Once activated, poly ADP-ribose polymerase repairs DNA breaks by covalently attaching ADP-ribose moieties derived from NAD to nuclear proteins. Consumption of NAD via increased activity of poly ADP-ribose polymerase then interferes with ATP synthesis (1 1, 12) . In lymphocytes and P388D1 cells, inhibition of poly ADP-ribose polymerase with nicotinamide or 3-aminobenzamide results in protection from NAD and ATP depletion and subsequent cell lysis (1 1-13, 23) .
To investigate the mechanisms of ATP depletion in endothelial cells, a prime target of oxidant injury, we performed similar experiments with human umbilical vein endothelial cells. We found that oxidant injury resulted in extensive DNA damage and that NAD and ATP levels fell coincident with the DNA damage. Like lymphocytes and P388D1 cells, we found that inhibition of poly ADP-ribose polymerase with nicotinamide or 3-aminobenzamide during oxidant stress protected the cell from NAD depletion. However, in contrast to the P388D1 cell line and lymphocytes, maintenance of NAD levels by inhibition of poly ADP-ribose polymerase did not protect the cell from ATP depletion. ATP depletion occurred despite maintenance of NAD levels.
To evaluate for other causes of the decline in ATP levels, we determined recovery of ATP exposed to glucose oxidase and xanthine oxidase in the absence of cells. The mechanism for the fall in intracellular ATP levels after oxidant injury was not the result of a direct interaction between hydrogen peroxide and ATP because recovery of ATP incubated with hydrogen peroxide generated by hypoxanthine-xanthine oxidase and glucose-glucose oxidase in the absence of cells was nearly 100%. The decline in intracellular ATP levels was not due to efflux of ATP from a damaged cell membrane because ATP was not detectable in the cell supernatants. Thus, neither depletion of ATP via activation of poly ADP-ribose polymerase, release of ATP via cell membrane damage, nor direct degradation of ATP by reactive oxygen molecules accounts for the profound depletion of ATP in human endothelial cells after oxidant stress. Inhibition of glycolysis via oxidant-induced injury of glyceraldehyde 3-phosphate dehydrogenase or oxidant-induced alterations of essential sulfhydryl groups of glucose-6-phosphate dehydrogenase are additional mechanisms that may contribute to ATP depletion after oxidant stress in human cells (12, 24) .
In previous studies, we and others have found that hydrogen peroxide was the reactive oxygen molecule responsible for injury after oxidant stress (6, 25, 26) . The addition of superoxide dismutase, a scavenger of superoxide anion, or mannitol, ethanol, and dimethylsulfoxide, each hydroxyl radical scavengers, did not prevent injury, whereas catalase, a scavenger of hydrogen peroxide, was effective. However, in cell-free systems, other studies have shown that hydroxyl radical derived from hydrogen peroxide mediates strand breaks (20, 27, 28) . In this study, we again found that catalase prevented DNA strand breaks, whereas scavengers of superoxide anion or hydroxyl radical did not. Although the hydroxyl radical scavengers did not prevent the DNA damage, it is likely that hydroxyl radical derived from hydrogen peroxide within the cell resulted in strand breaks and that the extracellular scavengers were inaccessible at the intracellular site of hydroxyl radical generation. Because the reactive oxygen molecules were generated extracellularly and because catalase was added to the extracellular environment, presumably catalase scavenged the hydrogen peroxide extracellularly before entry into the cell.
In conclusion, we report that oxidant injury to human umbilical vein endothelial cells results in profound DNA damage and in NAD and ATP depletion. NAD depletion results from activation of the DNA-repairing enzyme poly ADP-ribose polymerase. In contrast, ATP depletion is not a result of activation of poly ADP-ribose polymerase and NAD depletion.
